MOG and Alzheimer disease: Interestingly however, calculating the percent change in the percent of MOG+ oligodendrocytes in FUS-treated compared to naive animals reveals an interesting trend in the relative effectiveness of astrocytic activation of OPCs in young compared to aged and progressed 3xTg-AD animals.